Shan Xu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 4
- Dermatology top 5%
- Physiology top 10%
-
- RNA modifications and cancer 5
- Metabolomics and Mass Spectrometry Studies 3
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Kiyoshi AriizumiPaul R. BergstresserDale EdelbaumJunxia MinFudi WangA. TakashimaG. Càceres‐DittmarAkira Takashima
- Cited by
- Cancer ResearchImmunologyDermatology
- Journals
- The Journal of Immunology (2 papers)Scientific Reports (3 papers)European Journal of Immunology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Shan Xu
30 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 265
- Immunology 317
- Dermatology 83
- Physiology 35
- Molecular Biology 473
Countries citing papers authored by Shan Xu
This map shows the geographic impact of Shan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Xu more than expected).
Fields of papers citing papers by Shan Xu
This network shows the impact of papers produced by Shan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Xu. The network helps show where Shan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 83 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 31 | |
| 7 | 2020 | 6 | |
| 8 | 2017 | 17 | |
| 9 | 2017 | 55 | |
| 10 | 2017 | 30 | |
| 11 | 2016 | 12 | |
| 12 | 2016 | 20 | |
| 13 | 2015 | 5 | |
| 14 | 2015 | 4 | |
| 15 | 2014 | 46 | |
| 16 | 2013 | 40 | |
| 17 | 1995 | 43 | |
| 18 | 1995 | 5 | |
| 19 | 1995 | 141 | |
| 20 | 1995 | 62 |
About Shan Xu
Shan Xu is a scholar working on Cancer Research, Anesthesiology and Pain Medicine and Immunology, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), T-cell and B-cell Immunology (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (265 citations), Immunology (317 citations) and Dermatology (83 citations). Shan Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Kiyoshi Ariizumi, Paul R. Bergstresser, Dale Edelbaum, Junxia Min, Fudi Wang, A. Takashima, G. Càceres‐Dittmar, Akira Takashima, Keisuke Hashimoto and Jisong Zhang. Their work appears in journals such as The Journal of Immunology, Scientific Reports and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.